Search Results - "BIBLE, K."
-
1
Efatutazone, an Oral PPAR-γ Agonist, in Combination With Paclitaxel in Anaplastic Thyroid Cancer: Results of a Multicenter Phase 1 Trial
Published in The journal of clinical endocrinology and metabolism (01-06-2013)“…Purpose: A phase 1 study was initiated to determine the safety, potential effectiveness, and maximal tolerated dose and recommended phase 2 dose of efatutazone…”
Get full text
Journal Article -
2
The anticancer effects of chaetocin are independent of programmed cell death and hypoxia, and are associated with inhibition of endothelial cell proliferation
Published in British journal of cancer (17-01-2012)“…Background: We previously reported that chaetocin has potent and selective anti-myeloma activity attributable to reactive oxygen species (ROS) induction…”
Get full text
Journal Article -
3
Old-growth CO2 flux measurements reveal high sensitivity to climate anomalies across seasonal, annual and decadal time scales
Published in Agricultural and forest meteorology (15-08-2012)“…► The old-growth forest is a small net sink of carbon over 10 years but exhibits high interannual variability. ► FNEE is closely linked to climate…”
Get full text
Journal Article -
4
Preliminary results from a phase II trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations
Published in Annals of oncology (01-10-2018)Get full text
Journal Article -
5
-
6
Quantification of terrestrial ecosystem carbon dynamics in the conterminous United States combining a process-based biogeochemical model and MODIS and AmeriFlux data
Published in Biogeosciences (21-09-2011)“…Satellite remote sensing provides continuous temporal and spatial information of terrestrial ecosystems. Using these remote sensing data and eddy flux…”
Get full text
Journal Article -
7
-
8
Dynamics of water transport and storage in conifers studied with deuterium and heat tracing techniques
Published in Plant, cell and environment (01-01-2006)“…ABSTRACT The volume and complexity of their vascular systems make the dynamics of long‐distance water transport in large trees difficult to study. We used heat…”
Get full text
Journal Article -
9
Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents : The importance of sequence of administration
Published in Cancer research (Chicago, Ill.) (15-08-1997)“…Flavopiridol, the first potent cyclin-dependent kinase inhibitor to undergo clinical trials as an antineoplastic agent in the United States, has attracted…”
Get full text
Journal Article -
10
Stand-level gas-exchange responses to seasonal drought in very young versus old Douglas-fir forests of the Pacific Northwest, USA
Published in Tree physiology (01-08-2009)“…This study examines how stand age affects ecosystem mass and energy exchange response to seasonal drought in three adjacent Douglas-fir (Pseudotsuga menziesii…”
Get full text
Journal Article -
11
Flavopiridol : A cytotoxic flavone that induces cell death in noncycling A549 human lung carcinoma cells
Published in Cancer research (Chicago, Ill.) (01-11-1996)“…Flavopiridol (NSC 649890, L86-8275), a potent inhibitor of cyclin-dependent kinase 1/p34cdc2 phosphorylation and kinase activity, is currently undergoing Phase…”
Get full text
Journal Article -
12
Antitumor Activity of VB-111, a Novel Antiangiogenic Virotherapeutic, in Thyroid Cancer Xenograft Mouse Models
Published in Genes & cancer (01-10-2011)“…VB-111 is an engineered antiangiogenic adenovirus that expresses Fas-c in angiogenic blood vessels and has previously been shown to have significant antitumor…”
Get full text
Journal Article -
13
Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer
Published in Cancer research (Chicago, Ill.) (15-05-2001)“…Differential display-PCR between ovarian tumor cell lines and short-term cultures of normal ovarian epithelial cell brushings was used to isolate a…”
Get full text
Journal Article -
14
Flavopiridol binds to duplex DNA
Published in Cancer research (Chicago, Ill.) (01-05-2000)“…Flavopiridol, the first potent cyclin-dependent kinase inhibitor to enter clinical trials, was recently found to be cytotoxic to noncycling cells. The present…”
Get full text
Journal Article -
15
The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux
Published in Cancer research (Chicago, Ill.) (15-01-2001)“…Because the activities of HER family members are elevated and/or aberrant in a variety of human neoplasms, these cell surface receptors are receiving…”
Get full text
Journal Article -
16
Effect of P-glycoprotein on flavopiridol sensitivity
Published in British journal of cancer (18-05-2001)“…Flavopiridol is the first potent inhibitor of cyclin-dependent kinases (CDKs) to enter clinical trials. Little is known about mechanisms of resistance to this…”
Get full text
Journal Article -
17
canopy water relations of old-growth Douglas-fir trees
Published in Trees (Berlin, West) (1999)“…We investigated whole tree water relations in 56-65 m tall, old-growth Pseudotsuga menziesii trees within the Wind River Canopy Crane site, Carson, Washington,…”
Get full text
Journal Article -
18
Cyclosporine A alleviates severe anaemia associated with refractory large granular lymphocytic leukaemia and chronic natural killer cell lymphocytosis
Published in British journal of haematology (01-05-1996)“…Large granular lymphocytic (LGL) leukaemia and chronic natural killer cell lymphocytosis (CNKL) are chronic indolent disorders often associated with…”
Get more information
Journal Article -
19
Characterization of an Ovarian Carcinoma Cell Line Resistant to Cisplatin and Flavopiridol
Published in Clinical cancer research (01-02-2000)“…Flavopiridol, the first inhibitor of cyclin-dependent kinases to enter clinical trials, has shown promising antineoplastic activity and is currently undergoing…”
Get full text
Journal Article -
20
Лечение токсических побочных эффектов у пациентов с распространенным медуллярным раком щитовидной железы
Published in Opukholi golovy i shei (03-04-2019)“…Большой прогресс в лечении распространенного медуллярного рака щитовидной железы за последние 5 лет достигнут благодаря одобрению 2 препаратов – вандетаниба и…”
Get full text
Journal Article